Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment for Advanced Pancreatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00948688
What this trial is testing

Vorinostat With XRT and 5-FU for Locally Advanced Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic CancerAdenocarcinoma of the Pancreas
Massachusetts General Hospital 10
Early research (Phase 1)Study completedNCT00003426
What this trial is testing

Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01304160
What this trial is testing

Role of Cyberknife Stereotactic Radiation Therapy (SBRT) Followed by Gemcitabine for Patients With Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic CancerUnresectable Pancreatic Cancer
Centre hospitalier de l'Université de Montréal (CHUM) 10
Testing effectiveness (Phase 2)Ended earlyNCT01921751
What this trial is testing

High or Standard Intensity Radiation Therapy After Gemcitabine Hydrochloride and Nab-paclitaxel in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery

Who this might be right for
Pancreatic AdenocarcinomaStage III Pancreatic Cancer
Radiation Therapy Oncology Group 20
Not applicableLooking for participantsNCT05187312
What this trial is testing

Registry for Advanced Endoscopy

Who this might be right for
CholangiocarcinomaPancreatic CancerSclerosing Cholangitis
Region Stockholm 1,000
Testing effectiveness (Phase 2)Study completedNCT02128100
What this trial is testing

Effects of Folfirinox and Stereotactic Body Radiation Therapy for Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Non-resectable
University of Louisville 5
Early research (Phase 1)Study completedNCT00003867
What this trial is testing

Irinotecan and Capecitabine in Treating Patients With Solid Tumors

Who this might be right for
Cancer
Montefiore Medical Center 30
Early research (Phase 1)Study completedNCT02138383
What this trial is testing

Enzalutamide in Combination With Gemcitabine and Nab-Paclitaxel for the Treatment of Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
H. Lee Moffitt Cancer Center and Research Institute 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT04887805
What this trial is testing

Lenvatinib and Pembrolizumab Maintenance Therapy for the Treatment of Patients of Advanced Unresectable Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Ductal AdenocarcinomaStage II Pancreatic Cancer AJCC v8Stage IIA Pancreatic Cancer AJCC v8+4 more
City of Hope Medical Center 28
Testing effectiveness (Phase 2)Study completedNCT00096083
What this trial is testing

Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer

Who this might be right for
Cancer
Delcath Systems Inc. 56
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06888648
What this trial is testing

Personalized Tumor Neoantigen MRNA Therapy for Advanced Pancreatic Cancer.

Who this might be right for
Pancreatic Cancer MetastaticPancreatic Cancer Non-resectable
Zhejiang University 30
Testing effectiveness (Phase 2)WithdrawnNCT06398587
What this trial is testing

Onvansertib in Combination With Gemcitabine and Nab-paclitaxel for the Treatment of Patients With Locally-advanced, Unresectable, or Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Locally Advanced Pancreatic Ductal AdenocarcinomaMetastatic Pancreatic Ductal AdenocarcinomaStage II Pancreatic Cancer AJCC v8+3 more
OHSU Knight Cancer Institute
Not applicableStudy completedNCT02680990
What this trial is testing

Resilience and Exercise in Advanced Cancer Treatment

Who this might be right for
Pancreatic AdenocarcinomaGastric AdenocarcinomaAdenocarcinoma of the Gastroesophageal Junction
Milton S. Hershey Medical Center 14
Early research (Phase 1)Study completedNCT01764477
What this trial is testing

Safety and Efficacy Study of PRI-724 Plus Gemcitabine in Subjects With Advanced or Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Advanced Pancreatic CancerMetastatic Pancreatic CancerPancreatic Adenocarcinoma
Prism Pharma Co., Ltd. 20
Testing effectiveness (Phase 2)Looking for participantsNCT06333314
What this trial is testing

Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI

Who this might be right for
Pancreatic AdenocarcinomaAmpulla of Vater CarcinomaAdrenocortical Carcinoma+5 more
UNICANCER 120
Early research (Phase 1)UnknownNCT02433626
What this trial is testing

Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies

Who this might be right for
Ovarian CancerFallopian Tube CancerEndometrial Cancer+7 more
Critical Outcome Technologies Inc. 51
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06513455
What this trial is testing

Irinotecan Liposome，Albumin Paclitaxel and Gemcitabine First-line Treatment for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Harbin Medical University 132
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06700603
What this trial is testing

Second-line Irinotecan Liposome Combination Regimen for Irinotecan-treated Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Rui-hua Xu, MD, PhD 48
Early research (Phase 1)UnknownNCT04660929
What this trial is testing

CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors

Who this might be right for
HER2-positiveAdenocarcinomaBile Duct Cancer+28 more
Carisma Therapeutics Inc 48
Early research (Phase 1)Study completedNCT01770132
What this trial is testing

Ultrasound-Guided Photodynamic Therapy With Photofrin & Gemcitabine for Patients With Locally Advanced Pancreatic Cancer

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasStage III Pancreatic Cancer
John DeWitt 12
Next Page